|
|
BIOLOGY OF NATIVE ALPHA-SYNUCLEIN TETRAMERS IN PARKINSON'S DISEASE |
| 5R01NS083845-04 |
SELKOE, DENNIS J |
NINDS |
2017 |
|
|
C9ORF72 IN MOTOR SYSTEM BIOLOGY AND ALS |
| 5R01NS089742-04 |
EGGAN, KEVIN C |
NINDS |
2017 |
|
|
NUCLEOCYTOPLASMIC TRANSPORT AND NUCLEAR PORE DISRUPTION IN ALS/FTD |
| 5R01NS094239-02 |
ROTHSTEIN, JEFFREY D |
NINDS |
2017 |
|
|
DETECTION OF POST-TRANSLATIONALLY MODIFIED PROTEINS AS A BIOMARKER PANEL FOR PARKINSON'S DISEASE |
| 5U01NS097051-02 |
WALT, DAVID R. |
NINDS |
2017 |
|
|
LINKING TAU STRUCTURE TO ITS FUNCTIONS AND MECHANISMS IN ALZHEIMER’S DISEASE |
| 1RF1AG051085-01A1 |
BLOOM, GEORGE S |
NIA |
2016 |
|
|
PROTEOSTASIS IN THE AGING AND ALZHEIMER'S DISEASE BRAIN: ARE THE ATASES NOVEL TARGETS? |
| 1RF1AG053937-01 |
PUGLIELLI, LUIGI |
NIA |
2016 |
|
|
ASSESSMENT OF ULTRSOUND-FACILITATED NEUROTHERAPEUTICS IN ALZHEIMER'S DISEASE |
| 2R01AG038961-06 |
KONOFAGOU, ELISA E |
NIA |
2016 |
|
|
CLAUDE D. PEPPER OLDER AMERICANS INDEPENDENCE CENTER AND COORDINATING CENTER |
| 3P30AG021332-14S1 |
KRITCHEVSKY, STEPHEN B. |
NIA |
2016 |
|
|
ADVANCING OUR UNDERSTANDING OF OLIGOMER TOXICITY IN AGE-RELATED AMYLOID DISORDERS |
| 5K99AG050764-02 |
EISELE, YVONNE SIMONE |
NIA |
2016 |
|
|
CHARACTERIZATION OF ATXN1 IN APP PROCESSING AND AD PATHOGENESIS |
| 5R00AG039482-05 |
ZHANG, CAN MARTIN |
NIA |
2016 |
